Precision BioSciences, Inc. (DTIL)
NASDAQ·Healthcare·Biotechnology
$7.08
+0.57%
Mkt Cap $62.43M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $9.07M | $34.20M | +276.90% | -$0.21 | $0.36 | +271.43% | — | — |
| Q4 2025 Nov 3, 2025 | $9.07M | $13.00K | -99.86% | -$0.31 | -$1.84 | -493.55% | — | — |
| Q3 2025 Aug 7, 2025 | $5.40M | $18.00K | -99.67% | -$0.09 | -$2.13 | -2266.67% | — | — |
| Q2 2025 May 15, 2025 | $6.27M | $29.00K | -99.54% | -$0.43 | -$2.21 | -413.95% | — | — |
| Q1 2025 Mar 26, 2025 | $10.00M | $638.00K | -93.62% | -$2.09 | -$3.20 | -53.11% | — | — |
| Q4 2024 Nov 4, 2024 | $4.28M | $576.00K | -86.53% | -$0.79 | -$2.83 | -258.23% | — | — |
| Q3 2024 Aug 1, 2024 | $8.36M | $49.90M | +496.87% | -$0.77 | $3.46 | +549.35% | — | — |
| Q2 2024 May 13, 2024 | $6.02M | $17.58M | +192.09% | -$0.45 | -$0.35 | +22.22% | — | — |
| Q1 2024 Mar 27, 2024 | $12.48M | $7.04M | -43.61% | $3.00 | -$3.35 | -211.67% | — | — |
| Q4 2023 Nov 7, 2023 | $12.48M | $13.12M | +5.13% | -$5.71 | -$3.00 | +47.46% | — | — |
| Q3 2023 Aug 4, 2023 | $6.38M | $19.79M | +210.17% | -$6.91 | -$3.00 | +56.58% | — | — |
| Q2 2023 May 9, 2023 | $5.67M | $8.78M | +54.85% | -$6.61 | -$6.91 | -4.54% | — | — |
| Q1 2023 Mar 9, 2023 | $6.81M | $10.60M | +55.62% | -$7.21 | -$7.81 | -8.32% | — | — |
| Q4 2022 Nov 8, 2022 | $9.86M | $7.36M | -25.31% | -$10.51 | -$6.61 | +37.11% | — | — |
| Q3 2022 Aug 8, 2022 | $4.97M | $3.82M | -23.18% | -$12.91 | -$13.21 | -2.32% | — | — |
| Q2 2022 May 9, 2022 | $7.73M | $3.32M | -57.11% | -$17.42 | -$13.81 | +20.72% | — | — |
| Q1 2022 Mar 15, 2022 | $9.04M | $6.34M | -29.87% | -$14.41 | -$11.41 | +20.82% | — | — |
| Q4 2021 Nov 10, 2021 | $81.93M | $24.04M | -70.66% | -$18.02 | -$5.71 | +68.31% | — | — |
| Q3 2021 Aug 12, 2021 | $68.81M | $68.81M | +0.00% | -$11.41 | $10.81 | +194.74% | — | — |
| Q2 2021 May 13, 2021 | $21.91M | $16.35M | -25.37% | -$14.71 | -$9.91 | +32.63% | — | — |